HCN1 pathogenic variants associated with childhood epilepsy in a cohort of Chinese patients

IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY
Zhuanyi Yang, Zhuo Kuang, Hongmei Liao, Siyi Gan, Xiaomei Peng, Haiyan Yang, Liwen Wu
{"title":"HCN1 pathogenic variants associated with childhood epilepsy in a cohort of Chinese patients","authors":"Zhuanyi Yang,&nbsp;Zhuo Kuang,&nbsp;Hongmei Liao,&nbsp;Siyi Gan,&nbsp;Xiaomei Peng,&nbsp;Haiyan Yang,&nbsp;Liwen Wu","doi":"10.1002/epd2.20182","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objective</h3>\n \n <p>HCN ion channel family has a widespread expression in neurons, and recently, increasing studies have demonstrated their roles in epilepsies.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Clinical data of the patients were gathered in a retrospective study. Exon sequencing was used for the patients with unexplained recurrent seizures and varying levels of developmental delay.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>In this study, eight de novo variants of <i>HCN1</i> genes were uncovered in eight patients, including six missense variants, one nonsense variant and one frameshift insertion variant; five of them were reported for the first time. The onset age for eight patients ranges from one month to one year. Their main clinical manifestations are epilepsy and varying degrees of developmental delay, and the main type of seizure is focal secondary generalized tonic–clonic seizure. Importantly, in our study, one case presented with a form of migrating focal seizure that has not been reported in the literature. Seizures from five of the eight children were effectively controlled with antiepileptic drugs including valproic acid, levetiracetam and oxcarbazepine. One child developed normally and four children developed mild delay. One child was treated with topiramate, and the convulsion was partially controlled and showed moderate to severe developmental delay. The antiepileptic treatment failed for the other two children, and the two children were treated with sodium valproate, oxcarbazepine, lamotrigine, chlorbazan, levetiracetam and nitrodiazepam successively, but their convulsions were not controlled and showed moderate to severe developmental delay.</p>\n </section>\n \n <section>\n \n <h3> Significance</h3>\n \n <p>Our research reported eight variants in <i>HCN1</i> gene causing epilepsy; among these variants, five variants were never reported before. <i>HCN1</i>-related epilepsy usually starts infantile period, and focal secondary generalized tonic–clonic seizure is the most common seizure type. Importantly, we reported the case with migrating focal seizure was rarely reported. Our study expanded both genotype and phenotype for <i>HCN1-</i>related epilepsy.</p>\n </section>\n </div>","PeriodicalId":50508,"journal":{"name":"Epileptic Disorders","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2023-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epileptic Disorders","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/epd2.20182","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

HCN ion channel family has a widespread expression in neurons, and recently, increasing studies have demonstrated their roles in epilepsies.

Methods

Clinical data of the patients were gathered in a retrospective study. Exon sequencing was used for the patients with unexplained recurrent seizures and varying levels of developmental delay.

Results

In this study, eight de novo variants of HCN1 genes were uncovered in eight patients, including six missense variants, one nonsense variant and one frameshift insertion variant; five of them were reported for the first time. The onset age for eight patients ranges from one month to one year. Their main clinical manifestations are epilepsy and varying degrees of developmental delay, and the main type of seizure is focal secondary generalized tonic–clonic seizure. Importantly, in our study, one case presented with a form of migrating focal seizure that has not been reported in the literature. Seizures from five of the eight children were effectively controlled with antiepileptic drugs including valproic acid, levetiracetam and oxcarbazepine. One child developed normally and four children developed mild delay. One child was treated with topiramate, and the convulsion was partially controlled and showed moderate to severe developmental delay. The antiepileptic treatment failed for the other two children, and the two children were treated with sodium valproate, oxcarbazepine, lamotrigine, chlorbazan, levetiracetam and nitrodiazepam successively, but their convulsions were not controlled and showed moderate to severe developmental delay.

Significance

Our research reported eight variants in HCN1 gene causing epilepsy; among these variants, five variants were never reported before. HCN1-related epilepsy usually starts infantile period, and focal secondary generalized tonic–clonic seizure is the most common seizure type. Importantly, we reported the case with migrating focal seizure was rarely reported. Our study expanded both genotype and phenotype for HCN1-related epilepsy.

在一组中国患者中与儿童癫痫相关的HCN1致病变异
目的:HCN离子通道家族在神经元中广泛表达,近年来越来越多的研究证实其在癫痫中的作用。方法:对患者的临床资料进行回顾性分析。外显子测序用于不明原因的反复发作和不同程度的发育迟缓的患者。结果:本研究在8例患者中发现了8个HCN1基因的新生变异,包括6个错义变异、1个无义变异和1个移码插入变异,其中5个为首次报道。8例患者发病年龄从1个月到1岁不等。其主要临床表现为癫痫和不同程度的发育迟缓,癫痫发作类型主要为局灶性继发性全身性强直阵挛发作。重要的是,在我们的研究中,一个病例提出了一种形式的迁移局灶性癫痫,尚未在文献中报道。八名儿童中有五名的癫痫发作得到了有效控制,包括丙戊酸、左乙拉西坦和奥卡西平。1名儿童发育正常,4名儿童发育轻度迟缓。1例患儿用托吡酯治疗,惊厥部分得到控制,表现为中度至重度发育迟缓。另外2例患儿抗癫痫治疗失败,先后给予丙戊酸钠、奥卡西平、拉莫三嗪、氯巴赞、左乙拉西坦、硝基地西泮治疗,但惊厥未得到控制,出现中重度发育迟缓。意义:本研究报道了8个引起癫痫的HCN1基因变异,其中5个变异未见报道。hcn1相关性癫痫通常始于婴儿期,局灶性继发性全身性强直-阵挛性发作是最常见的发作类型。重要的是,我们报告了迁移局灶性癫痫的病例很少被报道。我们的研究扩展了hcn1相关癫痫的基因型和表型。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Epileptic Disorders
Epileptic Disorders 医学-临床神经学
CiteScore
4.10
自引率
8.70%
发文量
138
审稿时长
6-12 weeks
期刊介绍: Epileptic Disorders is the leading forum where all experts and medical studentswho wish to improve their understanding of epilepsy and related disorders can share practical experiences surrounding diagnosis and care, natural history, and management of seizures. Epileptic Disorders is the official E-journal of the International League Against Epilepsy for educational communication. As the journal celebrates its 20th anniversary, it will now be available only as an online version. Its mission is to create educational links between epileptologists and other health professionals in clinical practice and scientists or physicians in research-based institutions. This change is accompanied by an increase in the number of issues per year, from 4 to 6, to ensure regular diffusion of recently published material (high quality Review and Seminar in Epileptology papers; Original Research articles or Case reports of educational value; MultiMedia Teaching Material), to serve the global medical community that cares for those affected by epilepsy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信